<DOC>
	<DOC>NCT01176201</DOC>
	<brief_summary>This is an open-label study to determine the ADME (Absorption, Disposition, Metabolism and Excretion) of 14C labeled SLV337 after a single dose of an oral suspension.</brief_summary>
	<brief_title>14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man</brief_title>
	<detailed_description>The Absorption, Disposition, Metabolism and Excretion of SLV337 will be investigated after a single dose of an oral suspension of 14C-SLV337.</detailed_description>
	<criteria>Inclusion Criteria BMI 18 28 kg/m2 SBP 90140 DBP 5090 Exclusion Criteria Seizures, Orthostatic hypotension</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>SLV337</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Relative bioavailability</keyword>
	<keyword>ADME</keyword>
</DOC>